Story perspectives

U.S. Officials Reassess 30-Year Direct Drug Ad Policy

2/28/2026

Summary

Story summary

U.S. officials are reconsidering direct-to-consumer pharmaceutical advertising after nearly 30 years of unrestricted practice.
Health and Human Services Secretary Robert F. Kennedy Jr. says such advertising fuels overmedication and higher costs.
Critics argue ads mislead patients, while studies show they can prompt treatment for depression and heart disease.
Research suggests removing drug ads could reduce new users of essential medications like statins.

1 of 1

Story summary

U.S. officials are reconsidering direct-to-consumer pharmaceutical advertising after nearly 30 years of unrestricted practice.
Health and Human Services Secretary Robert F. Kennedy Jr. says such advertising fuels overmedication and higher costs.
Critics argue ads mislead patients, while studies show they can prompt treatment for depression and heart disease.
Research suggests removing drug ads could reduce new users of essential medications like statins.